0

Thermosensitive Hydrogels Based on Polypeptides for Localized and Sustained Delivery of Anticancer Drugs

Yilong Cheng, Chaoliang He, Jianxun Ding, Chunsheng Xiao, Xiuli Zhuang, Xuesi Chen

Biomaterials. 2013 Dec;34(38):10338-47.

PMID: 24095250

Abstract:

Thermosensitive hydrogels based on poly(γ-ethyl-L-glutamate)-poly(ethylene glycol)-poly(γ-ethyl-L-glutamate) triblock copolymers (PELG-PEG-PELG) were prepared for localized and sustained delivery of anticancer drugs. The polypeptide-based hydrogels showed much lower critical gelation concentration than the traditional polyester-based hydrogels. In vivo biocompatibility studies revealed that the in situ formed gels in the subcutaneous layer last for ≈ 21 days, and H&E staining study suggested acceptable biocompatibility of our materials in vivo. Then the hydrogels were tried as injectable implants to encapsulate antitumor drug, paclitaxel (PTX), to assess the in situ anti-tumoral activity using liver cancer xenograft model. The results demonstrated that the PTX-incorporated hydrogels could efficiently suppress the tumor growth, and did not result in obvious damage to normal organs. Therefore, the polypeptide-based thermosensitive hydrogels designed in the present study have great potential to serve as an effective platform for localized anti-cancer drug delivery.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP25189520 Poly(γ-ethyl-L-glutamate) Poly(γ-ethyl-L-glutamate) 25189-52-0 Price
qrcode